<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1679-4974</journal-id>
<journal-title><![CDATA[Epidemiologia e Serviços de Saúde]]></journal-title>
<abbrev-journal-title><![CDATA[Epidemiol. Serv. Saúde]]></abbrev-journal-title>
<issn>1679-4974</issn>
<publisher>
<publisher-name><![CDATA[Secretaria de Vigilância em Saúde e Ambiente - Ministério da Saúde do Brasil]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1679-49742020000100014</article-id>
<article-id pub-id-type="doi">10.5123/s1679-497420120000100010</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Avaliação do Sistema de Vigilância da Tuberculose Drogarresistente, Brasil, 2013-2017]]></article-title>
<article-title xml:lang="es"><![CDATA[Evaluación del Sistema de Vigilancia de la Tuberculosis Drogorresistente, Brasil, 2013-2017]]></article-title>
<article-title xml:lang="en"><![CDATA[Evaluation of the Drug-Resistant Tuberculosis Surveillance System, Brazil, 2013-2017]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tourinho]]></surname>
<given-names><![CDATA[Bruna Dias]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[Patrícia Bartholomay]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Gabriela Drummond Marques da]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rocha]]></surname>
<given-names><![CDATA[Marli Souza]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Penna]]></surname>
<given-names><![CDATA[Estefânia Quilma Andrade de Araújo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pércio]]></surname>
<given-names><![CDATA[Jadher]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Ministério da Saúde Secretaria de Vigilância em Saúde Programa de Treinamento em Epidemiologia Aplicada aos Serviços do Sistema Único de Saúde]]></institution>
<addr-line><![CDATA[Brasília DF]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Ministério da Saúde Secretaria de Vigilância em Saúde Coordenação Geral de Vigilância das Doenças de Transmissão Respiratória de Condições Crônicas]]></institution>
<addr-line><![CDATA[Brasília DF]]></addr-line>
<country>Brazil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<volume>29</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_arttext&amp;pid=S1679-49742020000100014&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_abstract&amp;pid=S1679-49742020000100014&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_pdf&amp;pid=S1679-49742020000100014&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Objetivo: avaliar o Sistema de Vigilância da Tuberculose Drogarresistente (SV-TBDR)/Brasil.  Métodos: estudo avaliativo, segundo diretrizes do Centro de Controle e Prevenção de Doenças, sobre dados nacionais do Sistema de Informação de Tratamentos Especiais de Tuberculose (SITETB) e do Sistema de Informação de Agravos de Notificação (Sinan) de 2013-2017.  Resultados: a completitude média dos dados foi de 95% (escolaridade [89,1%; 5.417/6.078]; nacionalidade [94,7%; 5.754/6.078]; raça/cor da pele [99,1%; 6.023/6.078]; tipo de resistência [98,6%; 5.995/6.078]; forma clínica [100%; 6.078/6.078]; e teste para HIV [87%; 5.289/6.078]); a proporção média de casos com culturas realizadas foi de 65,7% (cultura 1 [94,8%; 5.764/6.078]; cultura 2 [69,8%; 4.241/6.078]; cultura 3 [54,7%; 3.324/6.078]; e cultura 4 [43,6%; 2.652/6.078]); em 2015, o SV-TBDR notificou 52% (1.197/2.300) dos casos multirresistentes estimados pela Organização Mundial da Saúde, 41,3% (990/2.400) em 2016 e 45,8% (1.100/2.400) em 2017.  Conclusão: a baixa sensibilidade do SV-TBDR recomenda melhorias no acesso ao diagnóstico da TBDR.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: evaluar el Sistema de Vigilancia de la Tuberculosis Drogorresistente (SV-TB -DR)/Brasil.  Métodos: estudio evaluativo, según directrices del Centro de Control y Prevención de Enfermedades, sobre datos nacionales del Sistema de Información de Tratamientos Especiales de Tuberculosis (SITETB) y del Sistema Nacional de Agravamientos de Notificación (Sinan) entre 2013 y 2017.  Resultados: la completitud promedio de los datos fue de 95% (escolaridad [89,1%; 5.417/6.078]; nacionalidad [94,7%; 5.754/6.078]; raza/color de la piel ­[99,1%; 6.023/6.078]; tipo de resistencia [98,6%; 5.995/6.078]; forma clínica [100%; 6.078/6.078]; y prueba de VIH [87%; 5.289/6.078]); la proporción promedio de los casos con cultivos realizados fue 65,7% (cultivo 1 [94,8%; 5.764/6.078]; cultivo 2 [69,8%; 4.241/6.078]; cultivo 3 [54,7%; 3.324/6.078]; y cultivo 4 [43,6%; 2.652/6.078]); el SV-TB-DR reportó en 2015 52% (1.197/2.300) de los casos multirresistentes estimados por la Organización Mundial de la Salud, 41,3% (990/2.400) en 2016 y 45,8% (1.100/2.400) en 2017.  Conclusión: la baja sensibilidad del SV-TB-DR sugiere la necesidad de mejorar el acceso al diagnóstico de TB-DR.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: to evaluate the Brazilian Drug-Resistant Tuberculosis Surveillance System (DRTB-SS).  Methods: this was an evaluative study, following Centers for Disease Control and Prevention guidelines, using national data from the Special Tuberculosis Treatment Information System (SITETB), and the Notifiable Diseases Information System (SINAN), from 2013 to 2017.  Results: average data completeness was 95% (schooling [89.1%; 5,417/6,078], nationality [94.7%; 5,754/6,078], race/skin color [99.1%; 6,023/6,078], type of resistance [98.6%; 5,995/6,078], clinical form [100%; 6,078/6,078], and HIV test [87%; 5,289/6,078]); average proportion of cases with sputum cultures performed was 65.7% (culture 1 [94.8%; 5,764/6,078], culture 2 [69.8%; 4,241/6,078], culture 3 [54.7%, 3,324/6,078], and culture 4 [43.6%; 2,652/6,078]); DRTB-SS reported 52% (1,197/2,300) of multi-resistant cases estimated by the World Health Organization in 2015, 41.3% (990/2,400) in 2016, and 45.8% (1,100/2,400) in 2017.  Conclusion: low DRTB-SS sensitivity suggests the need for improved access to DRTB diagnosis.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Tuberculose Resistente a Múltiplos Medicamentos]]></kwd>
<kwd lng="pt"><![CDATA[Sistemas de Informação]]></kwd>
<kwd lng="pt"><![CDATA[Monitoramento Epidemiológico]]></kwd>
<kwd lng="pt"><![CDATA[Vigilância em Saúde Pública]]></kwd>
<kwd lng="es"><![CDATA[Tuberculosis Resistente a Múltiples Medicamentos]]></kwd>
<kwd lng="es"><![CDATA[Sistemas de Información]]></kwd>
<kwd lng="es"><![CDATA[Monitoreo Epidemiológico]]></kwd>
<kwd lng="es"><![CDATA[Vigilancia en Salud Pública]]></kwd>
<kwd lng="en"><![CDATA[Tuberculosis, Multidrug-Resistant]]></kwd>
<kwd lng="en"><![CDATA[Information Systems]]></kwd>
<kwd lng="en"><![CDATA[Epidemiological Monitoring]]></kwd>
<kwd lng="en"><![CDATA[Public Health Surveillance]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Global tuberculosis report 2018 [Internet]]]></source>
<year>2018</year>
<publisher-loc><![CDATA[World Health Organization ]]></publisher-loc>
<publisher-name><![CDATA[Geneva]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Coordenação Geral de Desenvolvimento da Epidemiologia em Serviços</collab>
<source><![CDATA[Guia de vigilância em saúde [Internet]]]></source>
<year>2019</year>
<edition>3 ed</edition>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dalcolmo]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[MKDN]]></given-names>
</name>
<name>
<surname><![CDATA[Picon]]></surname>
<given-names><![CDATA[PD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tuberculose multirresistente no Brasil: histórico e medidas de controle]]></article-title>
<source><![CDATA[Rev Saúde Pública [Internet]]]></source>
<year>2007</year>
<volume>41</volume>
<numero>^sSuppl 1</numero>
<issue>^sSuppl 1</issue>
<supplement>Suppl 1</supplement>
<page-range>34-42</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Ministe&#769;rio da Sau&#769;de (BR). Secretaria de Vigila&#770;ncia em Sau&#769;de.Centro de Referência Professor Hélio Fraga</collab>
<source><![CDATA[Projeto MSH. Tuberculose multirresistente - guia de vigilância epidemiológica [Internet]]]></source>
<year>2007</year>
<edition>90</edition>
<publisher-loc><![CDATA[Rio de Janeiro ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bartholomay]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Pinheiro]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Pelissari]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Arakaki-Sanchez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Dockhorn]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rocha]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sistema de informação de tratamentos especiais de tuberculose: (SITETB): histórico, descrição e perspectivas]]></article-title>
<source><![CDATA[Epidemiol Serv Saúde [Internet]]]></source>
<year>2019</year>
<volume>28</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[German]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
<name>
<surname><![CDATA[Westmoreland]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<collab>Guidelines Work Group</collab>
<article-title xml:lang=""><![CDATA[Updated guidelines for evaluating public health surveillance systems]]></article-title>
<source><![CDATA[MMWR Morb Mortal Wkly Rep [Internet]]]></source>
<year>2001</year>
<volume>50</volume>
<numero>RR13</numero>
<issue>RR13</issue>
<page-range>1-35</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malhão]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Codennoti]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moherdaui]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Avaliação da completitude do Sistema de Informação de Agravos de Notificação da Tuberculose, Brasil, 2001-2006]]></article-title>
<source><![CDATA[Epidemiol Serv Saúde [Internet]]]></source>
<year>2010</year>
<volume>19</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>245-56</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[PB]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Codenotti]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Saraceni]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Nóbrega]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Sobel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Avaliação do sistema de vigilância da tuberculose no município do Rio de Janeiro, 2001 a 2006]]></article-title>
<source><![CDATA[Cad Saúde Coletiva [Internet]]]></source>
<year>2010</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>337-46</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[GDM]]></given-names>
</name>
<name>
<surname><![CDATA[Bartholomay]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[OG]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Avaliação da qualidade dos dados, oportunidade e aceitabilidade da vigilância da tuberculose nas microrregiões do Brasil]]></article-title>
<source><![CDATA[Ciênc Saúde Coletiva [Internet]]]></source>
<year>2017</year>
<volume>22</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>3307-19</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilhelm]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Nakata]]></surname>
<given-names><![CDATA[PT]]></given-names>
</name>
<name>
<surname><![CDATA[Godoy]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Blatt]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Descentralização do acesso ao sistema de informações de tratamentos especiais em tuberculose]]></article-title>
<source><![CDATA[Rev Baiana Enferm [Internet]]]></source>
<year>2018</year>
<volume>32</volume>
</nlm-citation>
</ref>
<ref id="B11">
<label>10</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde (BR)</collab>
<source><![CDATA[Departamento de Informática do SUS (Tabnet): demográficas e socioeconômicas. Projeção da população do Brasil por sexo e idade simples [Internet]]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chin]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[National survey of drug-resistant tuberculosis in China]]></article-title>
<source><![CDATA[N Engl J Med [Internet]]]></source>
<year>2012</year>
<volume>366</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>2161-70</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kuyinu]]></surname>
<given-names><![CDATA[YA]]></given-names>
</name>
<name>
<surname><![CDATA[Odugbeni]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Salisu-Olatunji]]></surname>
<given-names><![CDATA[SO]]></given-names>
</name>
<name>
<surname><![CDATA[Adepoju]]></surname>
<given-names><![CDATA[FO]]></given-names>
</name>
<name>
<surname><![CDATA[Odusanya]]></surname>
<given-names><![CDATA[OO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics of mycobacterium tuberculosis positive patients screened for drug-resistant tuberculosis at a tertiary health facility in Lagos, Nigeria]]></article-title>
<source><![CDATA[J Natl Med Assoc [Internet]]]></source>
<year>2017</year>
<volume>110</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>88-91</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Correia]]></surname>
<given-names><![CDATA[LOS]]></given-names>
</name>
<name>
<surname><![CDATA[Padilha]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Vasconcelos]]></surname>
<given-names><![CDATA[SML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Métodos para avaliar a completitude dos dados dos sistemas de informação em saúde do Brasil: uma revisão sistemática]]></article-title>
<source><![CDATA[Ciênc Saúde Coletiva [Internet]]]></source>
<year>2014</year>
<volume>19</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>4467-78</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<source><![CDATA[Fatores associados à subnotificação de TB e Aids, durante os anos de 2001 a 2010, a partir do Sinan]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Recife, PE ]]></publisher-loc>
<publisher-name><![CDATA[Fundação Instituto Oswaldo Cruz]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[VMM]]></given-names>
</name>
<name>
<surname><![CDATA[Brant]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Arsky]]></surname>
<given-names><![CDATA[MLS]]></given-names>
</name>
<name>
<surname><![CDATA[Araújo]]></surname>
<given-names><![CDATA[WN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Avaliação do sistema nacional de vigilância epidemiológica da leptospirose - Brasil, 2007]]></article-title>
<source><![CDATA[Cad Saúde Coletiva [Internet]]]></source>
<year>2010</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>95-105</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dunn]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Andreoli]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Captura e recaptura: nova metodologia para pesquisas epidemiológicas]]></article-title>
<source><![CDATA[Rev Saúde Pública [Internet]]]></source>
<year>1994</year>
<volume>28</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>449-53</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abdolmugnhi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Abdulwareth]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Hamady]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mahyoub]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Alagbari]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Serouri]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of multi drug resistant tuberculosis surveillance system, Yemen]]></article-title>
<source><![CDATA[Iproc [Internet]]]></source>
<year>2018</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B19">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Belanger]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Morris]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
<name>
<surname><![CDATA[Brostrom]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Yost]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Goswami]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Oxtoby]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Introduction and evaluation of multidrug-resistant tuberculosis supplemental surveillance in the United States]]></article-title>
<source><![CDATA[J Clin Tuberc Other Mycobact Dis [Internet]]]></source>
<year>2019</year>
<volume>15</volume>
<numero>2019</numero>
<issue>2019</issue>
<page-range>100090</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[MTC]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[LGD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adesão ao tratamento para Tuberculose Multidroga-Resistente (TBMDR): estudo de caso em ambulatório de referência, Niterói (RJ), Brasil]]></article-title>
<source><![CDATA[Cad Saúde Coletiva [Internet]]]></source>
<year>2019</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>108-15</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>19</label><nlm-citation citation-type="journal">
<collab>Ministério da Saúde (BR). Secretaria de Vigilância em Saúde</collab>
<article-title xml:lang=""><![CDATA[Brasil livre da tuberculose: evolução dos cenários epidemiológicos e operacionais da doença]]></article-title>
<source><![CDATA[Bol Epidemiol [Internet]]]></source>
<year>2019</year>
<volume>50</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1-18</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>20</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde (BR)</collab>
<source><![CDATA[Agency for International Development (USA). System for improved access to pharmaceuticals and services. Brasil - pesquisa de avaliação dos usuários do SITE-TB, 2016]]></source>
<year>2016</year>
<publisher-loc><![CDATA[[S.n.] ]]></publisher-loc>
<publisher-name><![CDATA[Arlington (VA)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramalho]]></surname>
<given-names><![CDATA[DMP]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[PFC]]></given-names>
</name>
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Brígido]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Dalcolmo]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Mesquita]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcome in patients with presumed drug resistant tuberculosis in five reference centers in Brazil]]></article-title>
<source><![CDATA[BMC Infect Dis [Internet]]]></source>
<year>2017</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>571</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viana]]></surname>
<given-names><![CDATA[PVS]]></given-names>
</name>
<name>
<surname><![CDATA[Redner]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fatores associados ao abandono de tuberculose drogarresistente (TBDR) atendidos em um centro de referência no Rio de Janeiro, Brasil]]></article-title>
<source><![CDATA[Cad Saúde Pública [Internet]]]></source>
<year>2018</year>
<volume>34</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B25">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fregona]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cosme]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
<name>
<surname><![CDATA[Moreira]]></surname>
<given-names><![CDATA[CMM]]></given-names>
</name>
<name>
<surname><![CDATA[Bussular]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Dettoni]]></surname>
<given-names><![CDATA[VV]]></given-names>
</name>
<name>
<surname><![CDATA[Dalcolmo]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fatores associados à tuberculose resistente no Espírito Santo, Brasil]]></article-title>
<source><![CDATA[Rev Saúde Pública [Internet]]]></source>
<year>2017</year>
<volume>51</volume>
<page-range>41</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
